Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Givinostat hydrochloride by Italfarmaco for Polycythemia Vera: Likelihood of Approval
Givinostat hydrochloride is under clinical development by Italfarmaco and currently in Phase III for Polycythemia Vera. According to GlobalData, Phase...
Data Insights
Givinostat hydrochloride by Italfarmaco for Duchenne Muscular Dystrophy: Likelihood of Approval
Givinostat hydrochloride is under clinical development by Italfarmaco and currently in Pre-Registration for Duchenne Muscular Dystrophy. According to GlobalData, Pre-Registration...